Literature DB >> 24287922

Ginsenoside Rg1 decreases neurofibrillary tangles accumulation in retina by regulating activities of neprilysin and PKA in retinal cells of AD mice model.

Yanhui He1, Haijun Zhao, Guanfang Su.   

Abstract

Neurofibrillary tangles (NFTs) are the major component of senile plaques in the brains of patients with Alzheimer's disease (AD). However, the mechanism causing NFTs accumulation in AD patients' retina is also elusive. Thus, we investigated the effects of ginsenoside Rg1 on NFTs accumulation in retinal pigment epithelial (RPE) cells isolated form double transgenic APP/PS1 mice model. NFTs amounts in culture supernatants were examined by enzyme-linked immunosorbent assay. Activity and mRNA transcription of enzymes and proteins that regulate NFTs accumulation were examined by activity assay and reverse transcription PCR. The expression of neprilysin (NEP) and neutral endopeptidase (PKA) were detected by western blot assay. Rg1 significantly decreased NFTs accumulation in isolated RPE cells. Activity of NEP was significantly increased, and activity of PKA was significantly decreased in cell lysates of Rg1-feeding APP/PS1 mice compared with non-Rg1-feeding mice. mRNA level of NEP was significantly higher and mRNA level of PKA was significantly lower in cells of Rg1-feeding mice than nonfeeding mice. The phosphorylation of tau at Thr231, Thr205, and Ser396 were significantly decreased in RPE of Rg1-feeding APP/PS1 mice compared with the non-Rg1-feeding mice. Rg1 decreased the NFTs production in RPE cell of APP/PS1 mice by modulating the expression and activity of NEP and PKA, which perform the function through downregulating the phosphorylation of tau protein.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24287922     DOI: 10.1007/s12031-013-0173-7

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  21 in total

1.  Ginsenoside Rg1 attenuates β-amyloid generation via suppressing PPARγ-regulated BACE1 activity in N2a-APP695 cells.

Authors:  Li-Min Chen; Zhi-Ying Lin; Yuan-Gui Zhu; Nan Lin; Jing Zhang; Xiao-Dong Pan; Xiao-Chun Chen
Journal:  Eur J Pharmacol       Date:  2011-12-07       Impact factor: 4.432

2.  Estrogenic effect of ginsenoside Rg1 on APP processing in post-menopausal platelets.

Authors:  Chun Shi; Ning Na; Xiaoming Zhu; Jie Xu
Journal:  Platelets       Date:  2012-02-28       Impact factor: 3.862

3.  Effects of ginsenoside Rg1 or 17β-estradiol on a cognitively impaired, ovariectomized rat model of Alzheimer's disease.

Authors:  X Zhang; J Wang; Y Xing; L Gong; H Li; Z Wu; Y Li; J Wang; Y Wang; L Dong; S Li
Journal:  Neuroscience       Date:  2012-06-19       Impact factor: 3.590

4.  Hippocampal neurofibrillary tangle changes and aggressive behaviour in dementia.

Authors:  Mitchell K P Lai; Christopher P Chen; Tony Hope; Margaret M Esiri
Journal:  Neuroreport       Date:  2010-12-08       Impact factor: 1.837

5.  Neuron loss from the hippocampus of Alzheimer's disease exceeds extracellular neurofibrillary tangle formation.

Authors:  Jillian J Kril; Smita Patel; Antony J Harding; Glenda M Halliday
Journal:  Acta Neuropathol       Date:  2001-12-12       Impact factor: 17.088

Review 6.  Tau phosphorylation in Alzheimer's disease: pathogen or protector?

Authors:  Hyoung-Gon Lee; George Perry; Paula I Moreira; Matthew R Garrett; Quan Liu; Xiongwei Zhu; Atsushi Takeda; Akihiko Nunomura; Mark A Smith
Journal:  Trends Mol Med       Date:  2005-04       Impact factor: 11.951

7.  [Effect of ginsenoside Rg1 on expressions of phosphory protein tau and N-methyl-D-aspartate receptor subunits NR1 and NR2B in rat brain slice model of Alzheimer's disease].

Authors:  Xi Li; Ying Liu; Xin Zhang; Haifeng Yuan; Qiankun Quan
Journal:  Zhongguo Zhong Yao Za Zhi       Date:  2010-12

8.  Synthesis and biological evaluation of novel styryl benzimidazole derivatives as probes for imaging of neurofibrillary tangles in Alzheimer's disease.

Authors:  Kenji Matsumura; Masahiro Ono; Masashi Yoshimura; Hiroyuki Kimura; Hiroyuki Watanabe; Yoko Okamoto; Masafumi Ihara; Ryosuke Takahashi; Hideo Saji
Journal:  Bioorg Med Chem       Date:  2013-03-29       Impact factor: 3.641

Review 9.  The aging eye: common degenerative mechanisms between the Alzheimer's brain and retinal disease.

Authors:  Jeremy M Sivak
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-01-30       Impact factor: 4.799

10.  Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease-like pathology and cognitive decline.

Authors:  Johannes Vom Berg; Stefan Prokop; Kelly R Miller; Juliane Obst; Roland E Kälin; Ileana Lopategui-Cabezas; Anja Wegner; Florian Mair; Carola G Schipke; Oliver Peters; York Winter; Burkhard Becher; Frank L Heppner
Journal:  Nat Med       Date:  2012-11-25       Impact factor: 53.440

View more
  8 in total

Review 1.  Clearance of Amyloid Beta and Tau in Alzheimer's Disease: from Mechanisms to Therapy.

Authors:  Shu-Hui Xin; Lin Tan; Xipeng Cao; Jin-Tai Yu; Lan Tan
Journal:  Neurotox Res       Date:  2018-04-07       Impact factor: 3.911

2.  Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease.

Authors:  Yosef Koronyo; David Biggs; Ernesto Barron; David S Boyer; Joel A Pearlman; William J Au; Shawn J Kile; Austin Blanco; Dieu-Trang Fuchs; Adeel Ashfaq; Sally Frautschy; Gregory M Cole; Carol A Miller; David R Hinton; Steven R Verdooner; Keith L Black; Maya Koronyo-Hamaoui
Journal:  JCI Insight       Date:  2017-08-17

Review 3.  Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology.

Authors:  Harald Hampel; Nicola Toschi; Claudio Babiloni; Filippo Baldacci; Keith L Black; Arun L W Bokde; René S Bun; Francesco Cacciola; Enrica Cavedo; Patrizia A Chiesa; Olivier Colliot; Cristina-Maria Coman; Bruno Dubois; Andrea Duggento; Stanley Durrleman; Maria-Teresa Ferretti; Nathalie George; Remy Genthon; Marie-Odile Habert; Karl Herholz; Yosef Koronyo; Maya Koronyo-Hamaoui; Foudil Lamari; Todd Langevin; Stéphane Lehéricy; Jean Lorenceau; Christian Neri; Robert Nisticò; Francis Nyasse-Messene; Craig Ritchie; Simone Rossi; Emiliano Santarnecchi; Olaf Sporns; Steven R Verdooner; Andrea Vergallo; Nicolas Villain; Erfan Younesi; Francesco Garaci; Simone Lista
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

4.  Fuzhisan, a chinese herbal medicine, suppresses beta-secretase gene transcription via upregulation of SIRT1 expression in N2a-APP695 cells.

Authors:  Ran Gao; Ye Wang; Qingge Pan; Gaoya Huang; Nan Li; Jing Mou; Desheng Wang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 5.  The impact of ginsenosides on cognitive deficits in experimental animal studies of Alzheimer's disease: a systematic review.

Authors:  Chenxia Sheng; Weijun Peng; Zi-An Xia; Yang Wang; Zeqi Chen; Nanxiang Su; Zhe Wang
Journal:  BMC Complement Altern Med       Date:  2015-10-24       Impact factor: 3.659

Review 6.  Ocular indicators of Alzheimer's: exploring disease in the retina.

Authors:  Nadav J Hart; Yosef Koronyo; Keith L Black; Maya Koronyo-Hamaoui
Journal:  Acta Neuropathol       Date:  2016-09-19       Impact factor: 17.088

7.  Fuzheng Quxie Decoction Ameliorates Learning and Memory Impairment in SAMP8 Mice by Decreasing Tau Hyperphosphorylation.

Authors:  Yang Yang; Xingxing Jia; Jianchao Feng; Zhiyong Wang; Yu Cao; Jiangang Liu; Hao Li
Journal:  Evid Based Complement Alternat Med       Date:  2017-12-20       Impact factor: 2.629

Review 8.  Panax ginseng components and the pathogenesis of Alzheimer's disease (Review).

Authors:  Mayya Petrovna Razgonova; Valery Vyacheslavovich Veselov; Alexander Mikhailovich Zakharenko; Kirill Sergeyevich Golokhvast; Alexander Evgenyevich Nosyrev; Giancarlo Cravotto; Aristidis Tsatsakis; Demetrios A Spandidos
Journal:  Mol Med Rep       Date:  2019-02-19       Impact factor: 2.952

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.